ROSEN, NATIONAL TRIAL LAWYERS, Encourages Proterra Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PTRA

NEW YORK, July 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Proterra Inc. (NASDAQ: PTRA) between August 2, 2022 and March 15, 2023, both dates inclusive (the “Class Period”), of the important September 12, 2023 lead plaintiff deadline. SO WHAT: If you purchased […]

Read More »

ROSEN, A TOP RANKED LAW FIRM, Encourages Danaher Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – DHR

NEW YORK, July 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Danaher Corporation (NYSE: DHR) between April 21, 2022 and April 24, 2023, both dates inclusive (the “Class Period”), of the important September 15, 2023 lead plaintiff deadline. SO WHAT: If you purchased […]

Read More »

APLS INVESTOR NOTICE: ROSEN, A LEADING NATIONAL FIRM, Encourages Apellis Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation – APLS

NEW YORK, July 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces that it is investigating potential securities claims on behalf of shareholders of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) resulting from allegations that Apellis may have issued materially misleading business information to the investing public. SO WHAT: If […]

Read More »

Bybit and Oracle Red Bull Racing Introduce ‘Velocity Series,’ a Groundbreaking Digital Art Collaboration

DUBAI, UNITED ARAB EMIRATES – Media OutReach – 24 July 2023 – Bybit, the world’s third most visited cryptocurrency exchange, is delighted to introduce the Velocity Series, an unprecedented collaboration between Bybit, Oracle Red Bull Racing, and renowned digital artists. This initiative will merge art and racing by creating unique digital collectibles inspired by race […]

Read More »

Curia expands biologics capabilities with access to Touchlight’s doggybone DNA

Curia collaborates with Touchlight to expand its mRNA manufacturing offering to enable access to enzymatic doggybone DNA (dbDNA™) ALBANY, N.Y. and HAMPTON, United Kingdom, July 24, 2023 (GLOBE NEWSWIRE) — Curia, a leading contract research, development and manufacturing organization, and Touchlight, a company pioneering enzymatic DNA production, today announced an agreement which will provide Curia […]

Read More »